chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PATIENT HAS PERSITENT PAIN AT INJECTION SITE PREVENTING PATIENT TO RAISE ARM WITHOUT DISCOMFORT OR SLEEP WELL DUE TO PAIN.  THE PAIN ALSO IS AFFECTING THE PATIENT SPORADICALLY THROUGHOUT THE DAY.  THE PATIENT SAID HE VISITIED HIS PRIMARY CARE PHYSICIAN WHO GAVE SAMPLES OF ORAL AND TOPICAL ANTI-INFLAMATORY AGENTS HOWEVER HAS NOT RELIEVED HIS DISCOMFORT.  I RECOMMENDED A TOPICAL ANALGESIC LIDOCAINE PATCH TO USE AND CONTACTED THE PHYSICIAN TO INFORM OF MY RECOMMENDATION.
Received booster at 0930 10/6/2021. Symptoms 12 hours of chills, fever, muscle weakness, nausea, jittery, felt like had to urinate , did void 3-4 times urine colorless; 22 hours after booster approximately 0745 am I got up to use bathroom, I remember seeing fading light. Fell on carpeted floor. Do not know how long I was out. Husband assisted me  back to bed. Weakness resulted but no further fainting. Legs felt heavy until about 2:30 pm 10/7/ 2021. Other symptoms of chills/ fever and feeling need to urinate and jitters subsided approximately 3:30-4 pm 10/7/2021. The next day felt weak but no other symptoms.
died; This is a spontaneous report from a non-contactable consumer, this consumer report same events for 5 patients, this is the 4 of five report.   A patient of unspecified age and gender received bnt162b2 (COMIRNATY), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. The patient died on an unspecified date.  It was not reported if an autopsy was performed. Reporter said they tried to say nurse didn't die, but she had an obituary so she clearly did die so that's just one, reporter had seen 4 self.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101524663 same reporter/product/event, different patient; Reported Cause(s) of Death: died
He presented with symptoms of fatigue and chest pain on 5/2/2021 to the Emergency room at the hospital. Troponin was 6.273 ng/ml. EKG demonstrated diffuse ST segment elevation. No pericardial rub on exam. Coronary arteriography was normal. Echocardiography demonstrated an LV ejection fraction of 57%. There was no pericardial effusion. Troponin peaked at 11.729. He responded well to treatment with high dose aspirin and colchicine. He was discharged from the hospital on 5/4/2021 with a diagnosis of myopericarditis. Repeat echo on 5/14/2021 normal LVEF of 55% and no pericardial effusion. Follow up outpatient visit on 5/17/2021 at health clinic. He was asymptomatic. Normal exam. Tape was tapering aspirin. To stop colchicine on 7/2/2021. Patient is a college student. Planned to return to his home in late June or July 2021. His mother  is listed as a contact person. Her phone number is (redacted) Thank you., MD MS FACC FSCAI.
Guillain-Barre syndrome; Initial information received on 18-Oct-2021 regarding an unsolicited valid Social Media serious case received from a consumer/non-health care professional.   This case involves an unknown age male patient who had guillain-barre syndrome after receiving vaccine INFLUENZA VACCINE.  The patient's medical history included Cardiovascular disease, unspecified (Cardiovascular disorder).  At the time of the event, the patient had ongoing Diabetes (Diabetes mellitus).  The patient's past medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  It was unknown if the patient had any concomitant disease or risk factor.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiration date not reported) via unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a serious guillain-barre syndrome (unknown latency) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant. The patient was hospitalized for this event.  It was unknown if the patient experienced any additional symptoms/events.   No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At time of reporting, the outcome was unknown for the reported event.  There will be no information on the batch number for this case.; Sender's Comments: This case concerns an an unknown age male patient who had guillain-barre syndrome after vaccination with INFLUENZA VACCINE (unknown manufacturer). The time to onset is compatible. The patient's medical history included Cardiovascular disorder. At the time of the event, the patient had ongoing Diabetes mellitus and other relevant laboratory data were not reported. Based upon the reported information, the role of a vaccine cannot be assessed.
Patient had 1st dose of COVID-19 vaccine on 01/15/2021. Tested positive for COVID-19 on 01/24/2021 and received bamlamivimab infusion on 01/26/2021.  She was told by pharmacist to restart the COVID-19 vaccine series since the first dose would be invalid.  She returned on 04/23/2021 for second dose and on 05/14/2021 for the third dose.
I texted positive for COVID-19, on August 5th, 2022. I had a fever that would not go down, my blood pressure would not stabilize, I had slight  diarrhea. The reason I went to the hospital is because I took an at home test and it was positive. They couldn't prescribe me PAXLOVID because I was taking other medication.
Had a positive PCR test for Covid on 8/25/21.  Symptoms felt mainly like sinus headache and post nasal drip,   ( (Never any  chest congestion)  that lasted for 4 days.  Extreme fatigue at first that waned over one month.   At 3 weeks , had s/s of intermittent tachycardia, and when lying supine had chest pain.
no adverse effect; improperly stored doses of varivax; This spontaneous report was received from a nurse refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies were not reported. The patient's concomitant medication included sterile diluent (Lot # n030413 and expiration date reported as 05-JUL-2020). On 28-JUL-2019, the patient was vaccinated with an improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (strength, dose, frequency were not reported, lot # s002874 has been verified to be a valid lot number for (varicella virus vaccine live (oka/merck)), expiration date reported as 29-JAN-2021) for prophylaxis (product storage error). Doses of suspect vaccine experienced the temperature excursion - 7.64 fahrenheit (-13.35 degree Celsius) for 20 minutes. It was reported that previous temperature excursion was present (19.34 F for 34 minutes). Data logger was involved. No adverse effects (adverse events) were reported. No product quality complaint was also reported. Outcome for the events was unknown.
Pt recv vax on 10/13/98; on 10/14/98 pt exp swollen arm
4CM round erythematous hard to touch area surrounding injection site to the left upper arm. Patient complaints of itching to the site only. No other symptoms. Did take Benadryl last night and ice pack applied today (10/30/15).
Right after injection had  vaccine taste  in her mouth  bodycache, chills, headache, nosebleed left nostril,could not move had joint pain,  nausea and loss of  appetite  ,arm tenderness swollen" Popeye arm" temp 99.5
Hives and rashes accompanied by itching in random areas on my body that occur daily (everyday) since receiving the second vaccine dose. Headaches that occur infrequently (3 times/week).
Patient reports an upset stomach and refers to dizziness, then faints. He is placed on a stretcher and emergency medical personnel evaluate the patient. Lower extremities are raised. Vital and dextro are monitored. Patient was evaluated by Dr. The family is directed to notify that the patient has a history of vasovagal whenever they are punctured, they must be placed on a stretcher to be punctured.
This spontaneous report was received from a nurse and refers to multiple unspecified patients of unknown demographics. No information about the patients' pertinent medical history, concomitant medications, drug reactions or allergies was provided. On unspecified dates, the patients were vaccinated with doses of improperly stored ROTATEQ oral liquid, lot # M040268 with expiration date on 14-MAY-2018 (dose was not reported). The vaccine underwent a temperature excursion of 0 to 1 degree Celsius for 40 hours. Digital data logger was not involved. The vaccine did not undergo any previous temperature excursions. No adverse effects were reported. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments:  US-009507513-1706USA001279: US-009507513-1706USA001280: US-009507513-1706USA001281: US-009507513-1706USA001282: US-009507513-1706USA001283: US-009507513-1706USA001284:
Throbbing, swelling, redness, warmth, swelling in lymph glands under arm and in neck. Antibiotic and steroid allergy med cool compress.
The pt experienced swelling 6cm x 4cm to the left arm with erythema and mildly warm to the touch.
I am an active 42 year old and run 5 days a week at a distance of  3 miles each run. I ran for the first time a few days after my shot and had a heart rate in the 190s during my 3 mile run. I typically hover in the 140s  range and have a resting heart rate in the 40s. My resting heart rate was 63 that day.  I did not exercise for another week based on medical advice and after a week of rest I attempted a cycle class on May 10. After four mintues of a warm up cycle, my heart rate was in the 170s and at that point I quit exercising (my resting heart rate that day was 75).  I let more time go and I am slowly beginning my normal exercise routine. My resting heart rate has been elevated since receving the first shot; however, my heart while exercising has seemed to return to the normal 140s range. My resting heart rate is in the 50s and 60s since receiving the first shot.
patient developed weakness on the right side of the face about 1 hour after receiving  the Gardasil
Patient came into public health on 11/3/2015 to report redness, warmth and erythema around injection site.  Prior to administering Prevnar 13, nurse observed a yellowish tinted small bruise about the size of a penny on the left deltoid.  Patient preferred to receive vaccine on the left deltoid after educating on preferences with increased risk of injection site irritation post vaccination.  Nurse outlined the redness as it was raised and warm measuring approximately 7cm x 4.5cm.  Patient was instructed to follow up with primary care doctor is symptoms did not resolve after icing over the next day or two.  Patient verbalized understanding and agreed to plan.
Had the flu shot done 3 weeks prior to the booster vaccine. In midway in the afternoon, after lunch, about 3 days after the booster, I noticed I was feeling anxious and uneasy. I have high blood pressure and took it and the results were normal, but I could not shake off the shaky feeling and anxiety. I went to go see my doctor who was concerned due to my blood pressure being higher then normal. He stated to just observe it to see it could be due to the vaccine so they would just monitor it. A week later I had my daily appointment with my endocrinologist, who also was concerned about my blood pressure it being even higher. He said lets do a couple of tests to see if it was a hormonal imbalance, and did blood tests and urine tests over the next 2 weeks, taking my regular meds in the meantime. They monitored my blood pressure over this time and though it was going down, it was still high. Both my primary and my endocrinologist communicated and stated they were going to try to put me on a dyer etic, and so I started Spironolactone 25mg on the 12/24/2021 and I am still on it and my blood pressure is slowly going down.
Diarrhea the following morning on 12/22/20. Last approximately 2-4 hours and resolved by the  evening on 12/22/20.
Came back positive today/ had a lot of nasal congestion, cough, and a sore throat; Came back positive today/ had a lot of nasal congestion, cough, and a sore throat; This is a spontaneous report from a contactable consumer via a medical information team. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration on 15Jan2021 as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Caller stated her husband, son, and her had the first COVID vaccine dose on 15Jan2021. 5 days later, her husband started having some symptoms. Her son this past Tuesday (26Jan2021), had a lot of nasal congestion, cough, and a sore throat. He had a COVID test yesterday and came back positive today (29Jan2021). Caller asking if the vaccine would resolve you getting a positive test for COVID or not. Caller asking if the vaccine would cause a positive test result. On 29Jan2021, the patient underwent lab tests and procedures which included COVID test: Positive. The outcome of the events was unknown.
About 15 minutes after receiving a flu shot, I suddenly felt all the blood drain from my face and my skin go clammy even though I was walking around. I felt dizzy, very lightheaded and nauseous and my visual surroundings became grainy and out of focus. I sat down and vomited and could not stand up for the next half hour.
Systemic: Chills-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium
Pt developed morbiliform rash 8 hours after administration of immunizations, no reaction previously. Negative respiratory/GI complaints. Benadryl administered po.
very tired,  migraine, low-grade fever, nausea, diarrhea, redness and swelling around the injection site.  I passed out twice due to weakness and lightheaded feeling.
p/vax pt exp pain inj site w/onset of tingling in lt arm; later persisting intermittently for 3-4wk;
ear pain; allergic sinusitis; This is a spontaneous report from a Pfizer Sponsored Program . A non-contactable consumer reported that a 34-year-old female patient received her second dose of bnt162b2 (BNT162B2 also reported as Pfizer-Biontech covid-19 vaccine, lot/batch number and expiry date were not reported), via an unspecified route of administration on 02Feb2021 at SINGLE DOSE for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced ear pain and allergic sinusitis on an unspecified date. She already took Tylenol as treatment. The outcome of event was unknown.    No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
vaccine administered after temperature excursion; This spontaneous case was reported by a health care professional and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (vaccine administered after temperature excursion) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (vaccine administered after temperature excursion). On 02-Apr-2021, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (vaccine administered after temperature excursion) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Information has been received from a mother concerning her 15 year old daughter who has had a liver transplant.  There were multiple concomitant medications but none were specified.  On 31-DEC-2007 the patient was vaccinated with her first dose of Gardasil.  The mother reported that her daughter fainted within 10 minutes after receiving the vaccination.  She passed out for about 1 minute after hitting her head.  She was seen in the emergency room and required 7 staples in her head to close the wound she received.  A CT of the head and neck was performed, as well as X-rays.  No results were reported.  Her head injury was considered to be immediately life-threatening and disabling.  Additional information has been requested.
Patient has been vomiting up breast milk and it now is projectile vomiting. Pt started vomiting 2 days after vaccine. Then by day 7 after vaccine pt started projective vomiting with breast feed. pt holding down PEDIALYTE without vomiting.
Information has been received from a physician concerning an 18 year old female who on 27-AUG-1992 was vaccinated with the first dose of MMR II, and the second dose on 14-OCT-1994. On 24-DEC-2009 the patient developed mumps. Date of mumps diagnosis reported as 03-DEC-2009. The patient had a fever of 102F and left parotitis. On 03-DEC-2009, blood work was performed (results not reported). At the time of the report, the patient's outcome was unknown. Follow up information has been received from the physician. It was reported that on 28-DEC-2009 (previously reported as 24-DEC-2009) the patient developed mumps. Date of mumps diagnosis reported as 30-NOV-2009 (previously reported as 03-DEC-2009). The patient had a fever of 100.6F and right parotitis (previously reported as left parotitis). At the time of the report, the patient's outcome was unknown. Follow up information has been received from the physician. On 30-NOV-2009, the first blood work was performed: serum mumps immunoglobulin M antibody 13.29; serum mumps immunoglobulin G antibody 0.26 and serum amylase 183. Additional information has been requested.
Patient states that she has swelling and hives and the left side of her body.  Referred pt to md or urgent care
The day after the 2nd dose of Moderna (9/16/21), the patient experienced confusion. A head CT performed on 9/20/21 which showed an acute/subacute ischemic stroke in right posterior parietal lobe.
This is a spontaneous report received from a contactable nurse. A 65-year-old female patient received PREVNAR 13, intramuscular (upper right arm) on 07Sep2017 around 1400 at single dose for routine vaccination. Medical history included infection on right and left shoulder which started in May2017 where streptococcus A was the organism for both shoulders; surgery on right shoulder on 22MAY2017; surgery on the left shoulder on 25MAY2017 and hypothyroidism. Concomitant medication included ongoing levothyroxine sodium (SYNTHROID) at 0.112 ug daily for hypothyroidism which the patient has been taking for 38 years and 10th year booster of tetanus vaccine (manufacturer unknown) intramuscularly (left upper arm) on 07Sep2017 at unknown dose for immunization. On 07Sep2017, the patient noticed redness after the injection. The redness was small and what you would expect after an injection. The patient expected the initial reaction to be soreness and redness for day 1 or 2. On 13Sep2017 the patient reported that redness has doubled, hot at the site, and it being a little bit swollen. At the time of the report the patient noticed that redness was worse and pretty prominent. The patient also reported that there is no tenderness if she palpates the site. The outcome of the events was not recovered.
After these multiple vaccines were administered, the pt stopped responding to her name, lost eye contact and failed to develop speech by the normal benchmarks. She was unable to regulate her emotions in many situations, resulting in tantrums or crying. When language did develop, it was scripted and not spontaneous. Also, she had repetitive speech, lining up her toys, no remorse when scolded, over-stuffing her mouth, seeks deep pressure and digs fingernails into other's bodies and bite, too. Observation by Peds Neuro and Developmental Peds. Review of medical records indicates child was diagnosed with bronchiolitis and L otitis media on 2/9/00. Based on medical records added provisional diagnosis of autistic spectrum disorder. Annual follow up states: Autism spectum disorder, self regulation dysfunction, speech delay, social language deficits, attending difficulties.
PATIENT WAS ADMINISTERED WITH ONLY MODERNA BOOSTER DOSE 0.25CC INSTEAD OF MODERNA 1ST DOSE 0.5CC. PATIENT RECEIVED ANOTHER 0.25CC MODERNA DOSE THE NEXT DAY WITHIN 24HRS FROM THE FIRST 0.25CC DOSE.
Received 2nd Pfizer COVID booster on 07/15/22...On 7/17/22, developed severe leg pains, bilaterally. Also, developed incontinence and needed foley catheter by 07/22/22.
Pain muscular, headache, nausea, heat muscular, for more information see anexo.
fever 14SEP; adm for viral meningitis 15SEP; transferred to another hosp 19SEP because of hypotonia; treatment w/Ampicillin/Cefotaxime then Acyyclovir; hypotonia showing some improvement w/PT;
Lot # is difficult to read on vaccination paperwork.  Approximately a 8-9 days after vaccination a small rash appeared at the injection site. It spread throughout my body from my scalp down to my mid thigh with itching and mild swelling. Urgent care prescribed prednisone and continued benadryl use, however, I am currently on day 4 of steroids with no improvement of rash.
Vaccinated 4/13/21 and 5/4/21.   Patient hospitalized for COVID-19 symptoms and tested positive for COVID-19.
This spontaneous report as received from a certified medical assistant to an 11 year old patient of an unknown gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. Approximately in 2015 (reported as 27-AUG-2015 to 03-SEP-2015) the patient was vaccinated with improperly stored dose of GARDASIL lot # K010215 with expiration date 05-MAY-2017 or lot # K011562 with expiration date 08-APR-2017; dose and route of administration were not reported. No adverse experiences were reported. This is one of the several reports received from same reporter. Additional information has been requested.
Got my period day after my first shot, and 15 days later I got my period again.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 28-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 28May2021 17:45 (Lot number: ER8734) at the age of 28 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: MENSTRUAL DISORDER (non-serious) with onset 29May2021 16:00, outcome "unknown", described as "Got my period day after my first shot, and 15 days later I got my period again.". The event "got my period day after my first shot, and 15 days later i got my period again." was evaluated at the physician office visit. Therapeutic measures were not taken as a result of menstrual disorder.  Additional information: The patient had no known allergies. The patient had received no other vaccines within 4 weeks prior to COVID vaccine. The patient had received no other medications within 2 weeks of vaccination. The patient had not diagnosed with COVID prior to vaccination and the patient had not tested to COVID post vaccination.  Follow-up attempts are completed. No further information is expected.
As soon as they injected the shot, the tips of my fingers began to feel numb. Seconds later, my fingers were numb. 3 in later my whole left arm was numb. Went to urgent care, was under observation for 2hrs.  Discharged me, went home and i still have no sensation on my arm. what do I do?